期刊文献+

TST对中老年男子PADAM患者临床症状及血脂水平的影响 被引量:2

EFFECTS OF TST ON CLINICAL SYMPTOMS AND SERUM LIPID LEVELS IN THE PADAM OF AGING MALE
下载PDF
导出
摘要 目的 :观察雄激素补充疗法 (Testosterone supplementation therapy,TST)对中老年男子部分雄激素缺乏症 (Partial an-drogen deficiency in aging m en,PADAM)患者临床更年期症状及血脂水平的影响。方法 :观察比较安慰剂对照组 16例 (对照组 )及十一酸睾酮治疗组 30例 (治疗组 )治疗前后更年期症状的评分、空腹血脂水平及肝肾功能的变化。结果 :对照组临床症状及血脂水平治疗前后无明显改变 (P >0 .0 5 ) ,而治疗组治疗后较治疗前临床症状明显改善 (P <0 .0 1) ,TC、TG、L DC- ch明显降低 (P <0 .0 5 ) ,HDL - ch无改变 (P >0 .0 5 )。治疗后 TC治疗组较对照组明显降低 (P <0 .0 5 ) ,临床症状较对照组明显改善 (P <0 .0 1)。结论 :中老年男子 PADAM患者 ,短期服用雄激素后可改善更年期症状及降低血 TC、TG及 L DC- ch水平。 Objective:To study changes both symptoms of andropause and serum lipid levels in TST of PADAM in aging male.Methods:16 cases in placebo and 30 cases in andriol treatment group were followed-up at pre-treatment and 6 month post-treatment respectively, The score of symptoms in andropause were determined and changes of serum lipid levels were observed.Result:The score of symptoms of andropause and serum lipid levels had no significantly change (P>0.05) in placebo group, and these were improved significantly (P<0.05) in andriol treatment group.Conclusion:TST could improve symptoms and declined the serum lipid levels of TC,TG and LDL-ch in short period in PADAM patients.
出处 《广西医科大学学报》 CAS 2003年第5期652-654,共3页 Journal of Guangxi Medical University
关键词 TST 中老年男子 PADAM 血脂 雄激素补充疗法 雄激素缺乏症 aging male PADAM TST serum lipids
  • 相关文献

参考文献8

  • 1[2]Huring BF,Seals DR,Hagberg JM.High-density lipopr-otein cholesterol in bodybuilders vs.powerlitfers:negative effects of androgen use.JAMA,1984,252:507.
  • 2[3]Arver S,Dobs AS,Meikle AW,et al.Long-term efficacy and safety of a permeation-enhanced testosterone trans-dermal system in hypogonadal men.Clin Endocrinol,1997,47:727.
  • 3[4]Tenover JS.Effects of testosterone supplementations in the aging male.J Clin Endocrinol Metab,1992,75:1092.
  • 4[5]Zgliczynske S,Ossowski M,Slowinska-Srzednicka J,et al.Effect of testosterone replacement therapy on lipids and lipoproteins in hypogonadal and elderly men.Arteriosclerosis,1996,121:35.
  • 5[6]Thompson PD,Calleinane EM,Sady SP,et al.Contrasti-ng effects of testosterone and stanozolol on serum lipoprotein levels.JAMA,1989,261:1165.
  • 6吴赛珠,翁心植.口服睾酮制剂对老年男性冠心病患者缓解心绞痛及降血脂作用观察[J].中华内科杂志,1993,32(4):235-238. 被引量:13
  • 7[8]Collaborative Group on Hormonal Factors in Breast Ca-ncer.Breast cancer and hormone replacement therapy:collaborative reanalysis of data from 51 epidemiological studies of 52,705 women with breast cancer and 108,411 without breast cancer.Lancet,1997,350:1047.
  • 8[9]Gooren IJG.A ten-year safety study of the oral androgen testosterone undecanoste.J Androl,1994,15:212.

二级参考文献2

  • 1崔志澄,1964年
  • 2杨晓春,中华医学杂志,1989年,69卷,329页

共引文献12

同被引文献29

  • 1张志超,孙斌,姚志勇,穆大为,周高标,洪泉,汪泽厚.中年男性雄激素部分缺乏症的睾酮补充治疗[J].中华泌尿外科杂志,2005,26(4):277-279. 被引量:5
  • 2曾永光,冯建华,邝世航,方玉林,区向阳.雄激素补充治疗PADAM观察[J].赣南医学院学报,2005,25(3):300-301. 被引量:2
  • 3李火金,史明,张忠林.中年男性雄激素部分缺乏症的临床治疗[J].深圳中西医结合杂志,2006,16(6):361-363. 被引量:2
  • 4Mulligan T, Frick MF, Zuraw QC, et al. Prevalence of hypogonadism in males aged at least 45 years: The HIM study. Int J Clin Pract, 2006, 60(7) : 762-769.
  • 5Jones RD, Nettleship JE, Kapoor D, et al. Testosterone and atherosclerosis in aging men: Purported association and clinical implications. Am J Cardiovasc Drugs, 2005, 5(3) : 141-154.
  • 6Yassin A, Saad F, Gooren LJ. Metabolic syndrome, testosterone deficiency and erectile dysfunction never come alone. Andrologia, 2008, 40(4) : 259-264.
  • 7Alexandersen P, Haarbo J, Christiansen C. The relationship of natural androgens to coronary heart disease in males: A review. Atheroselerosis, 1996, 125( 1 ) : 1-13.
  • 8Wild RA, Grubb B, Hartz A, et al. Clinical signs of androgen excess as risk factors for coronary artery disease. Fertil Steril, 1990, 54(2): 255-259.
  • 9Liu Y, Ding J, Bush TL, et al. Relative androgen excess and increased cardiovascular risk after menopause : A hypothesized relation. Am J Epidemiol, 2001, 154(6) : 489-494.
  • 10Sih R, Morley JE, Kaiser FE, et al. Testosterone replacement in older hypogonadal men: A 12-month randomized controlled trial. J Clin Endocrinol Metab, 1997, 82(6) : 1661-1667.

引证文献2

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部